Literature DB >> 4042425

Serum from patients with pernicious anaemia blocks gastrin stimulation of acid secretion by parietal cells.

H J de Aizpurua, B Ungar, B H Toh.   

Abstract

We examined 51 sera from patients with pernicious anaemia for their capacity to block maximal gastrin stimulation of acid secretion by isolated rodent gastric parietal cells. 14C-aminopyrine accumulation was used as the index of acid secretion in vitro. Sera from patients with pernicious anaemia gave significantly (P less than 0.005) more block of maximal gastrin stimulation of acid secretion (61.7 +/- 37.8%) than sera from 10 patients with systemic lupus erythematosus (19.6 +/- 17.7%), 10 with scleroderma (34.2 +/- 22.3%), five with rheumatoid arthritis (22.4 +/- 15.6%) or 30 from healthy persons (27.4 +/- 12.8%). Maximal histamine stimulation of acid secretion was not inhibited. The blocking factor was present in serum IgG fractions, and serum and IgG fractions gave parallel dose-response and dilution curves. The serum block was abolished by absorption with gastric mucosal cells and correlated with the presence of parietal cell surface autoantibody. We conclude that serum immunoglobulin in pernicious anaemia can block gastrin stimulation of acid secretion and suggest that this block may be mediated by competition with gastrin for surface receptors on parietal cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042425      PMCID: PMC1577303     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.

Authors:  T Mittag; P Kornfeld; A Tormay; C Woo
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

Review 2.  A reappraisal of the nature and significance of chronic atrophic gastritis.

Authors:  R G Strickland; I R Mackay
Journal:  Am J Dig Dis       Date:  1973-05

3.  Immunopharmacological disease: a break in tolerance to receptor sites.

Authors:  V A Lennon; P R Carnegie
Journal:  Lancet       Date:  1971-03-27       Impact factor: 79.321

4.  Serum gastrin concentrations in pernicious anemia.

Authors:  J E McGuigan; W L Trudeau
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

5.  Evidence to suggest that LATS protector stimulates the human thyroid gland.

Authors:  D D Adams; T H Kennedy
Journal:  J Clin Endocrinol Metab       Date:  1971-07       Impact factor: 5.958

6.  Vulnerability of cell-surface receptors to autoimmune reactions.

Authors:  P R Carnegie; I R Mackay
Journal:  Lancet       Date:  1975-10-11       Impact factor: 79.321

7.  Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.

Authors:  J S Flier; C R Kahn; J Roth; R S Bar
Journal:  Science       Date:  1975-10-03       Impact factor: 47.728

8.  Secretagogue stimulation of [14C]aminopyrine accumulation by isolated canine parietal cells.

Authors:  A H Soll
Journal:  Am J Physiol       Date:  1980-04

9.  Autoantibodies to beta 2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma.

Authors:  J C Venter; C M Fraser; L C Harrison
Journal:  Science       Date:  1980-03-21       Impact factor: 47.728

10.  Effects of secretagogues on oxygen consumption, aminopyrine accumulation and morphology in isolated gastric glands.

Authors:  T Berglindh; H F Helander; K J Obrink
Journal:  Acta Physiol Scand       Date:  1976-08
View more
  2 in total

1.  Absence of a gastrin inhibitory factor in the IgG fraction of serum from patients with pernicious anaemia.

Authors:  J T Smith; A Garner; S E Hampson; R E Pounder
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

2.  Monoclonal antibody to the gastrin receptor on parietal cells recognizes a 78-kDa protein.

Authors:  F T Mu; G Baldwin; J Weinstock; D Stockman; B H Toh
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.